Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
02/1999
02/09/1999US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds
02/09/1999US5869230 Gene transfer into the kidney
02/09/1999US5868757 For use with an imaging device
02/05/1999CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses
02/05/1999CA2239270A1 Novel phosphoribosyl transferase
02/05/1999CA2238673A1 Novel aminopeptidase
02/04/1999WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS
02/04/1999WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS
02/04/1999WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
02/04/1999WO1999005132A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
02/04/1999WO1999005113A1 Substituted 6-phenylphenanthridines
02/04/1999WO1999005112A1 Substituted 6-alkylphenanthridines
02/04/1999WO1999005111A1 Novel tetrazole derivatives
02/04/1999WO1999005095A1 Aminocycloalkane compounds
02/04/1999WO1999005090A1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
02/04/1999WO1999004822A2 New salts with beneficial organoleptic properties
02/04/1999WO1999004791A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999WO1999004782A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
02/04/1999WO1999004780A1 Therapeutic or prophylactic agent for glomerulopathy
02/04/1999WO1999004773A2 Method for inhibiting bone resorption
02/04/1999CA2298507A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999CA2298053A1 Novel estrogen receptor .beta. and isoforms
02/04/1999CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors
02/04/1999CA2297907A1 Human estrogen receptor beta
02/04/1999CA2297315A1 Endothelin receptor antagonists
02/04/1999CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
02/04/1999CA2296329A1 Aminocycloalkane compounds
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894856A1 A human sMAD3 splice variant
02/03/1999EP0894806A1 Novel pheS
02/03/1999EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof
02/03/1999EP0894089A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
02/03/1999CN1207042A A Pharmaceutical composition for the treatment of autommune diseases
02/02/1999US5866702 Purine inhibitors of cyclin dependent kinase 2
02/02/1999US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host.
02/02/1999US5866679 Peptides
02/02/1999US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them
02/02/1999US5866571 Treatment of inflammations, thromboembolic diseases and cardiovascular diseases.
02/02/1999US5866568 Heterocyclic compounds
02/02/1999US5866559 Hormone replacement therapy; endometrioses
02/02/1999US5866535 Forming antibodies
02/02/1999US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.?
02/01/1999CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis
01/1999
01/29/1999CA2239266A1 Novel histidine kinase
01/28/1999WO1999003831A1 3-benzoylindole derivatives and drugs containing the same
01/28/1999WO1999003483A1 Use of neurotoxin therapy for treatment of urologic and related disorders
01/28/1999WO1998046589A3 Indazole amide compounds as serotoninergic agents
01/28/1999DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists
01/28/1999CA2521392A1 Use of neurotoxin therapy for treatment of urologic and related disorders
01/28/1999CA2294772A1 3-benzoylindole derivatives and drugs containing the same
01/27/1999EP0893503A2 Regulator protein from Staphylococcus aureus
01/27/1999EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0893121A1 Oral liquid medicine solution
01/27/1999EP0892809A1 Fhit proteins and nucleic acids and methods based thereon
01/27/1999EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
01/27/1999EP0892790A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
01/27/1999EP0892788A1 Novel carboxylic acid derivatives, their production and use
01/27/1999EP0892787A1 NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
01/27/1999EP0892786A1 New carboxylic acid derivatives, their production and use
01/27/1999EP0796243B1 Diaminocyclobutene-3,4-diones
01/27/1999CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives
01/27/1999CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
01/26/1999US5864043 Cardiovascular disorders and angiotensin antagonist
01/26/1999US5863913 Aromatic compound and pharmaceutical composition
01/26/1999US5863900 Lhrh antagonists
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999CA1340329C Superoxide dismutasee
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/23/1999CA2238674A1 Novel tetracycline resistance protein
01/23/1999CA2238665A1 Novel reductase
01/23/1999CA2238611A1 Novel lyss
01/23/1999CA2238608A1 Novel cyss
01/21/1999WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
01/21/1999WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES
01/21/1999WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
01/21/1999WO1999002180A1 Immunogenic lhrh compositions and methods relating thereto
01/21/1999WO1999002175A1 Conjugates useful in the treatment of prostate cancer
01/21/1999CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives
01/21/1999CA2295860A1 Conjugates useful in the treatment of prostate cancer
01/21/1999CA2294865A1 Immunogenic lhrh compositions and methods relating thereto
01/21/1999CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
01/20/1999EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
01/20/1999EP0892057A2 Response regulator
01/20/1999EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor
01/20/1999EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives
01/20/1999EP0891364A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
01/20/1999EP0891363A1 Heterocyclic compounds and their preparation and use
01/20/1999EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
01/20/1999EP0891361A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891360A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891357A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891356A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891355A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891353A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891352A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891351A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891350A1 Inhibitors of farnesyl-protein transferase
01/20/1999EP0891349A1 Inhibitors of farnesyl-protein transferase